137 related articles for article (PubMed ID: 19527686)
21. TFII-I and AP2α Co-Occupy the Promoters of Key Regulatory Genes Associated with Craniofacial Development.
Miranda P; Enkhmandakh B; Bayarsaihan D
Cleft Palate Craniofac J; 2018 Jul; 55(6):865-870. PubMed ID: 28085512
[TBL] [Abstract][Full Text] [Related]
22. Genomic organization of the genes Gtf2ird1, Gtf2i, and Ncf1 at the mouse chromosome 5 region syntenic to the human chromosome 7q11.23 Williams syndrome critical region.
Bayarsaihan D; Dunai J; Greally JM; Kawasaki K; Sumiyama K; Enkhmandakh B; Shimizu N; Ruddle FH
Genomics; 2002 Jan; 79(1):137-43. PubMed ID: 11827466
[TBL] [Abstract][Full Text] [Related]
23. Essential role of the N-terminal region of TFII-I in viability and behavior.
Lucena J; Pezzi S; Aso E; Valero MC; Carreiro C; Dubus P; Sampaio A; Segura M; Barthelemy I; Zindel MY; Sousa N; Barbero JL; Maldonado R; Pérez-Jurado LA; Campuzano V
BMC Med Genet; 2010 Apr; 11():61. PubMed ID: 20403157
[TBL] [Abstract][Full Text] [Related]
24. Comparison of TFII-I gene family members deleted in Williams-Beuren syndrome.
Hinsley TA; Cunliffe P; Tipney HJ; Brass A; Tassabehji M
Protein Sci; 2004 Oct; 13(10):2588-99. PubMed ID: 15388857
[TBL] [Abstract][Full Text] [Related]
25. The nuclear localization pattern and interaction partners of GTF2IRD1 demonstrate a role in chromatin regulation.
Carmona-Mora P; Widagdo J; Tomasetig F; Canales CP; Cha Y; Lee W; Alshawaf A; Dottori M; Whan RM; Hardeman EC; Palmer SJ
Hum Genet; 2015 Oct; 134(10):1099-115. PubMed ID: 26275350
[TBL] [Abstract][Full Text] [Related]
26. Epigenetic modulation by TFII-I during embryonic stem cell differentiation.
Bayarsaihan D; Makeyev AV; Enkhmandakh B
J Cell Biochem; 2012 Oct; 113(10):3056-60. PubMed ID: 22628223
[TBL] [Abstract][Full Text] [Related]
27. Negative autoregulation of GTF2IRD1 in Williams-Beuren syndrome via a novel DNA binding mechanism.
Palmer SJ; Santucci N; Widagdo J; Bontempo SJ; Taylor KM; Tay ES; Hook J; Lemckert F; Gunning PW; Hardeman EC
J Biol Chem; 2010 Feb; 285(7):4715-24. PubMed ID: 20007321
[TBL] [Abstract][Full Text] [Related]
28. Multiple GTF2I-like repeats of general transcription factor 3 exhibit DNA binding properties. Evidence for a common origin as a sequence-specific DNA interaction module.
Vullhorst D; Buonanno A
J Biol Chem; 2005 Sep; 280(36):31722-31. PubMed ID: 15987678
[TBL] [Abstract][Full Text] [Related]
29. Isolation and characterization of BEN, a member of the TFII-I family of DNA-binding proteins containing distinct helix-loop-helix domains.
Bayarsaihan D; Ruddle FH
Proc Natl Acad Sci U S A; 2000 Jun; 97(13):7342-7. PubMed ID: 10861001
[TBL] [Abstract][Full Text] [Related]
30. A transcriptomic study of Williams-Beuren syndrome associated genes in mouse embryonic stem cells.
De Cegli R; Iacobacci S; Fedele A; Ballabio A; di Bernardo D
Sci Data; 2019 Nov; 6(1):262. PubMed ID: 31695049
[TBL] [Abstract][Full Text] [Related]
31. Alternative splicing and promoter use in TFII-I genes.
Makeyev AV; Bayarsaihan D
Gene; 2009 Mar; 433(1-2):16-25. PubMed ID: 19111598
[TBL] [Abstract][Full Text] [Related]
32. GTF2IRD1 in craniofacial development of humans and mice.
Tassabehji M; Hammond P; Karmiloff-Smith A; Thompson P; Thorgeirsson SS; Durkin ME; Popescu NC; Hutton T; Metcalfe K; Rucka A; Stewart H; Read AP; Maconochie M; Donnai D
Science; 2005 Nov; 310(5751):1184-7. PubMed ID: 16293761
[TBL] [Abstract][Full Text] [Related]
33. Evolution of general transcription factors.
Gunbin KV; Ruvinsky A
J Mol Evol; 2013 Feb; 76(1-2):28-47. PubMed ID: 23229069
[TBL] [Abstract][Full Text] [Related]
34. Determination and functional analysis of the consensus binding site for TFII-I family member BEN, implicated in Williams-Beuren syndrome.
Lazebnik MB; Tussie-Luna MI; Roy AL
J Biol Chem; 2008 Apr; 283(17):11078-82. PubMed ID: 18326499
[TBL] [Abstract][Full Text] [Related]
35. Regulation of alternative splicing of Gtf2ird1 and its impact on slow muscle promoter activity.
Tay ES; Guven KL; Subramaniam N; Polly P; Issa LL; Gunning PW; Hardeman EC
Biochem J; 2003 Sep; 374(Pt 2):359-67. PubMed ID: 12780350
[TBL] [Abstract][Full Text] [Related]
36. Positive and negative regulation of the transforming growth factor beta/activin target gene goosecoid by the TFII-I family of transcription factors.
Ku M; Sokol SY; Wu J; Tussie-Luna MI; Roy AL; Hata A
Mol Cell Biol; 2005 Aug; 25(16):7144-57. PubMed ID: 16055724
[TBL] [Abstract][Full Text] [Related]
37. Expression profiling of BEN regulated genes in mouse embryonic fibroblasts.
Chimge NO; Mungunsukh O; Ruddle F; Bayarsaihan D
J Exp Zool B Mol Dev Evol; 2007 May; 308(3):209-24. PubMed ID: 17041962
[TBL] [Abstract][Full Text] [Related]
38. [Expression of GTF2IP23 in breast cancer and it mediated regulation of GTF2I].
Zhou SW; Su BB; Feng YQ; Du XQ; Zhao H
Zhonghua Zhong Liu Za Zhi; 2019 Dec; 41(12):918-922. PubMed ID: 31874549
[No Abstract] [Full Text] [Related]
39. A transcription factor involved in skeletal muscle gene expression is deleted in patients with Williams syndrome.
Tassabehji M; Carette M; Wilmot C; Donnai D; Read AP; Metcalfe K
Eur J Hum Genet; 1999; 7(7):737-47. PubMed ID: 10573005
[TBL] [Abstract][Full Text] [Related]
40. Identification of GTF2IRD1, a putative transcription factor within the Williams-Beuren syndrome deletion at 7q11.23.
Franke Y; Peoples RJ; Francke U
Cytogenet Cell Genet; 1999; 86(3-4):296-304. PubMed ID: 10575229
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
